Pharmaceutical Market Europe • July/August 2025 • 45

HEALTHCARE COMMS

Bedrock unveils new brand identity to reflect agency evolution

Image

Bedrock Healthcare Communications, a Resonant Group company, has unveiled a new brand identity that “represents a pivotal moment” in the agency’s evolution.

The rebrand, launched earlier this year, centres around the concept of ‘Imagine More’ and aims to reflect Bedrock’s response to significant shifts in client needs, industry complexity and the opportunity for medical communications to deliver greater impact in a resource-constrained world.

Supported by a fresh visual identity and refined messaging, the rebrand follows an “intensive strategic exercise” conducted last year, which included client interviews, competitive benchmarking and full-team workshops, Bedrock said.

The insights gained from this led to the creation of ‘Imagine More’, a concept built on four pillars: scientific excellence; agility and adaptability; meaningful differentiation and true allyship.

Emily Wigginton, head of client services at Bedrock, said: “Medical affairs has become more central than ever to how pharmaceutical companies engage healthcare professionals (HCPs) and drive evidence-based decision-making.

“The purpose of ‘Imagining More’ for our clients, our people and the industry highlights that improving lives starts with meaningful scientific engagement that bridges the gap between science, HCPs and patients. But doing this meaningfully requires more than execution, it requires imagination and thinking beyond the possible. That’s where ‘Imagine More’ comes in.”

As part of the refreshed positioning, Bedrock will place a greater focus on strategic tools and delivery models, including sharpening its proprietary ARISE framework for medical engagement, as well as developing Bedrock ENGAGE, a new HCP engagement offering.

It is also planning to expand its client partnerships, invest further in strategic talent and evolve its offer in line with industry needs, particularly in rare disease, immunology, neurology and oncology.

David Youds, chief executive officer of parent company Resonant Group, said: “We’re immensely proud of the trust our clients place in us. And what’s even more exciting is how Bedrock has grown, not just in size, but in confidence, capability and clarity of purpose. This rebrand reflects all of this…”

Louise Adamson, Bedrock’s head of scientific services, added: “We wanted our brand to reflect who we’ve become and what we stand for. An agency that thinks ahead, moves fast and partners deeply, while never losing sight of the science or the people behind it.”


Emotive moves London office
to HealthTech hub

Image

Emotive has announced that its London office has relocated to Hale House, a HealthTech innovation hub situated in Portland Place, Marylebone.

The global medical communications agency, which spent a decade at its previous site, said the move “marks an exciting new chapter in [its] continued growth” and “aligns perfectly with [its] vision for the future”.

Emotive’s chief executive officer, Chris Edmonds, said: “This move is more than just a change of address. It reflects our ambition to continually evolve, grow and better serve our clients as their trusted partner.”

Edmonds added that, following the success of the move, the agency is now also looking for a “new, equally collaborative office for [its] growing Boston-based team”.

Spanning three buildings across a total of 38,000 square feet, Hale House has been designed to encourage innovation, facilitate collaboration and drive solutions to improve healthcare.

The hub is equipped with private offices, co-working spaces, meeting rooms and dedicated event spaces, and also offers dry lab facilities.

“Surrounded by like-minded innovators and positioned in a vibrant area of London, the new space fosters greater collaboration, creativity and connection, both internally and with clients,” Emotive said.

0